RDY
· Pharmaceuticals

Dr. Reddy's Laboratories

Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$12.17
-0.08 (-0.65%)
As of Oct 2, 4:30 PM ET ·
Analyst Consensus
Strong Sell
45
Analysts
Very High
Coverage
Buy 14 31%
Hold 11 24%
Sell 20 44%
Price in Context
52-Week High
$1,379.70
-99.1% from high
52-Week Low
$1,020.00
+-98.8% from low
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +16.4%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +17.0%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +10.4%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +21.9%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.6%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +201.1%